Literature DB >> 22532586

Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages.

Delisha A Stewart1, Yinmeng Yang, Liza Makowski, Melissa A Troester.   

Abstract

Basal-like breast cancer (BBC) is an aggressive subtype of breast cancer that has no biologically targeted therapy. The interactions of BBCs with stromal cells are important determinants of tumor biology, with inflammatory cells playing well-recognized roles in cancer progression. Despite the fact that macrophage-BBC communication is bidirectional, important questions remain about how BBCs affect adjacent immune cells. This study investigated monocyte-to-macrophage differentiation and polarization and gene expression in response to coculture with basal-like versus luminal breast cancer cells. Changes induced by coculture were compared with changes observed under classical differentiation and polarization conditions. Monocytes (THP-1 cells) exposed to BBC cells in coculture had altered gene expression with upregulation of both M1 and M2 macrophage markers. Two sets of M1 and M2 markers were selected from the PCR profiles and used for dual immunofluorescent staining of BBC versus luminal cocultured THP-1s, and cancer-adjacent, benign tissue sections from patients diagnosed with BBCs or luminal breast cancer, confirming the differential expression patterns. Relative to luminal breast cancers, BBCs also increased differentiation of monocytes to macrophages and stimulated macrophage migration. Consistent with these changes in cellular phenotype, a distinct pattern of cytokine secretion was evident in macrophage-BBC cocultures, including upregulation of NAP-2, osteoprotegerin, MIG, MCP-1, MCP-3, and interleukin (IL)-1β. Application of IL-1 receptor antagonist (IL-1RA) to cocultures attenuated BBC-induced macrophage migration. These data contribute to an understanding of the BBC-mediated activation of the stromal immune response, implicating specific cytokines that are differentially expressed in basal-like microenvironments and suggesting plausible targets for modulating immune responses to BBCs. 2012 AACR

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532586      PMCID: PMC3640417          DOI: 10.1158/1541-7786.MCR-11-0604

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  60 in total

1.  Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression.

Authors:  Xuezheng Sun; Patricia Casbas-Hernandez; Carol Bigelow; Liza Makowski; D Joseph Jerry; Sallie Smith Schneider; Melissa A Troester
Journal:  Breast Cancer Res Treat       Date:  2011-10-15       Impact factor: 4.872

Review 2.  Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation.

Authors:  Darwin J Prockop; Joo Youn Oh
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

3.  Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.

Authors:  Tricia H Burdo; Margaret R Lentz; Patrick Autissier; Anitha Krishnan; Elkan Halpern; Scott Letendre; Eric S Rosenberg; Ronald J Ellis; Kenneth C Williams
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

4.  Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer.

Authors:  Patrick G Morris; Clifford A Hudis; Dilip Giri; Monica Morrow; Domenick J Falcone; Xi Kathy Zhou; Baoheng Du; Edi Brogi; Carolyn B Crawford; Levy Kopelovich; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-27

5.  Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome.

Authors:  Michael J Campbell; Nathan Y Tonlaar; Elisabeth R Garwood; Dezheng Huo; Dan H Moore; Andrey I Khramtsov; Afred Au; Frederick Baehner; Yinghua Chen; David O Malaka; Amy Lin; Oyinlolu O Adeyanju; Shihong Li; Can Gong; Michael McGrath; Olufunmilayo I Olopade; Laura J Esserman
Journal:  Breast Cancer Res Treat       Date:  2010-09-15       Impact factor: 4.872

6.  CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.

Authors:  Bin-Zhi Qian; Jiufeng Li; Hui Zhang; Takanori Kitamura; Jinghang Zhang; Liam R Campion; Elizabeth A Kaiser; Linda A Snyder; Jeffrey W Pollard
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

7.  CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.

Authors:  David G DeNardo; Jairo B Barreto; Pauline Andreu; Lesley Vasquez; David Tawfik; Nikita Kolhatkar; Lisa M Coussens
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

8.  Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples.

Authors:  Fathi Elloumi; Zhiyuan Hu; Yan Li; Joel S Parker; Margaret L Gulley; Keith D Amos; Melissa A Troester
Journal:  BMC Med Genomics       Date:  2011-06-30       Impact factor: 3.063

9.  Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition.

Authors:  Gali Soria; Maya Ofri-Shahak; Ilana Haas; Neora Yaal-Hahoshen; Leonor Leider-Trejo; Tal Leibovich-Rivkin; Polina Weitzenfeld; Tsipi Meshel; Esther Shabtai; Mordechai Gutman; Adit Ben-Baruch
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

Review 10.  The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.

Authors:  L Bingle; N J Brown; Claire E Lewis
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996

View more
  48 in total

1.  Transitions from mono- to co- to tri-culture uniquely affect gene expression in breast cancer, stromal, and immune compartments.

Authors:  Mary C Regier; Lindsey J Maccoux; Emma M Weinberger; Keil J Regehr; Scott M Berry; David J Beebe; Elaine T Alarid
Journal:  Biomed Microdevices       Date:  2016-08       Impact factor: 2.838

2.  Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer.

Authors:  Sneha Sundaram; Alex J Freemerman; Amy R Johnson; J Justin Milner; Kirk K McNaughton; Joseph A Galanko; Katharine M Bendt; David B Darr; Charles M Perou; Melissa A Troester; Liza Makowski
Journal:  Breast Cancer Res Treat       Date:  2013-11-12       Impact factor: 4.872

3.  Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer.

Authors:  Heather Ann Brauer; Liza Makowski; Katherine A Hoadley; Patricia Casbas-Hernandez; Lindsay J Lang; Erick Romàn-Pèrez; Monica D'Arcy; Alex J Freemerman; Charles M Perou; Melissa A Troester
Journal:  Clin Cancer Res       Date:  2012-12-12       Impact factor: 12.531

4.  Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma.

Authors:  Q Wang; Y Lu; R Li; Y Jiang; Y Zheng; J Qian; E Bi; C Zheng; J Hou; S Wang; Q Yi
Journal:  Leukemia       Date:  2017-06-19       Impact factor: 11.528

5.  Sialylation and desialylation dynamics of monocytes upon differentiation and polarization to macrophages.

Authors:  Dan Wang; Evgeny Ozhegov; Lin Wang; Aimin Zhou; Huan Nie; Yu Li; Xue-Long Sun
Journal:  Glycoconj J       Date:  2016-04-14       Impact factor: 2.916

6.  The Transcriptome of Estrogen-Independent Mammary Growth in Female Mice Reveals That Not All Mammary Glands Are Created Equally.

Authors:  Grace E Berryhill; Danielle G Lemay; Josephine F Trott; Lucila Aimo; Adam L Lock; Russell C Hovey
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

7.  Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.

Authors:  Delisha A Stewart; Jason H Winnike; Susan L McRitchie; Robert F Clark; Wimal W Pathmasiri; Susan J Sumner
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

Review 8.  The inflammation highway: metabolism accelerates inflammatory traffic in obesity.

Authors:  Amy R Johnson; J Justin Milner; Liza Makowski
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

9.  Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype.

Authors:  Alex J Freemerman; Amy R Johnson; Gina N Sacks; J Justin Milner; Erin L Kirk; Melissa A Troester; Andrew N Macintyre; Pankuri Goraksha-Hicks; Jeffery C Rathmell; Liza Makowski
Journal:  J Biol Chem       Date:  2014-02-03       Impact factor: 5.157

10.  p53 and NF-κB coregulate proinflammatory gene responses in human macrophages.

Authors:  Julie M Lowe; Daniel Menendez; Pierre R Bushel; Maria Shatz; Erin L Kirk; Melissa A Troester; Stavros Garantziotis; Michael B Fessler; Michael A Resnick
Journal:  Cancer Res       Date:  2014-04-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.